Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure). (Q51654594)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 September 2010

Language	Label	Description	Also known as
English	Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure).	scientific article published on 28 September 2010

Statements

scholarly article

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT-proBNP Guided Management of Heart Failure--SIGNAL-HF (Swedish Intervention study--Guidelines and NT-proBNP AnaLysis in Heart Failure). (English)

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

5

object named as

Karl Swedberg

1 reference

Europe PubMed Central

9 April 2018

author name string

Hans Persson

1

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

Hans Erntell

2

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

Björn Eriksson

3

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

Gunilla Johansson

4

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

Ulf Dahlström

6

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

publication date

28 September 2010

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

European Journal of Heart Failure

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

12

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

12

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

1300-1308

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Usefulness of natriuretic peptides in primary health care: an exploratory study in elderly patients.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Identification and guided treatment of ventricular dysfunction in general practice using blood B-type natriuretic peptide.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Primary care-based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ169

21 January 2018

Identifiers

10.1093/EURJHF/HFQ169

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

1 reference

Europe PubMed Central

9 April 2018

http://europepmc.org/abstract/MED/20876734

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51654594&oldid=1541571283"